Misuse Of Drugs – Page 3

Misuse Of Drugs – Page 3

Page 1 | Page 2 | Page 3 | Page 4 | Page 5

Misuse of Drugs, Offences, Confiscation and Money Laundering

Page 3 – Class A (continued); Class B and Class C


(e) {20} any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,
(i) by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;
(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;
(iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;
(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;
(v) by formation of an N-oxide or of a quaternary base.

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrophan.

3. Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above not being a substance for the time being specified in Part II of this Schedule. {21}

4. Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.

5. Any preparation of other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.

6. Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.



Part II Class B Drugs.
1. The following substances and products, namely:

(a) {22} Acetyldihydrocodeine
Amphetamine
Cannabinol {109}
Cannabinol derivatives {109}
Cannabis and cannabis resin {106}{109}
Codeine
[Dexamphetamine] {23}
Dihydrocodeine
Ethylmorphine (3-ethylmorphine)
Glutethimide {24}
Lefetamine {25}
Mecloqualone {26}
Methaqualone {27}
Methcathinone {89}
4–Methylmethcathinone {113}
[Methylamphetamine] {108} {moved to class A}
a-methylphenethylhydoxlamine {95}
Methylphenidate
Methylphenobarbitone {28}
Nicocodine
Nicodicodine (6-nicotinoyldihydrocodeine) {29}
Norcodeine
Pentazocine {30}
Phenmetrazine
Pholcodine
Propiram {31}
Zipeprol {90}

{(aa) Any compound (not being bupropion, cathinone, diethylpropion, pyrovalerone or a compound for the time being specified in sub–paragraph (a) above) structurally derived from 2–amino–1–phenyl–1–propanone by modification in any of the following ways, that is to say,
(i) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(ii) by substitution at the 3–position with an alkyl substituent;
(iii) by substitution at the nitrogen atom with alkyl or dialkyl groups, or by inclusion of the nitrogen atom in a cyclic struc-ture.} {114}

(ab) Any compound structurally derived from 2–aminopropan–1–one by substitution at the 1-position with any monocyclic, orfused-polycyclic ring system (not being a phenyl ring or alkylenedioxyphenyl ring system), whether or not the compound is further modified in any of the following ways, that is to say,
(i) by substitution in the ring system to any extent with alkyl, alkoxy, haloalkyl or halide substituents, whether or not further substituted in the ring system by
one or more other univalent substituents;
(ii) by substitution at the 3–position with an alkyl substituent;
(iii) by substitution at the 2-amino nitrogen atom with alkyl or dialkyl groups, or by inclusion of the 2-amino nitrogen atom in a cyclic structure. {118}

(ac) Any compound (not being pipradrol) structurally derived from piperidine, pyrrolidine, azepane, morpholine or pyridine by substitution at a ring carbon atom with a diphenylmethyl group, whether or not the compound is further modified in any of the following ways, that is to say,
(i) by substitution in any of the phenyl rings to any extent with alkyl, alkoxy, haloalkyl or halide groups;
(ii) by substitution at the methyl carbon atom with an alkyl, hydroxyalkyl or hydroxy group;
(iii) by substitution at the ring nitrogen atom with an alkyl, alkenyl, haloalkyl or hydroxyalkyl group. {119}

(b) any 5,5 disubstituted barbituric acid. {32}

[(c):
(2,3–Dihydro–5–methyl–3–(4–morpholinylmethyl)pyrrolo[1, 2, 3–de]–1,4–benzoxazin–6–yl]–1–naphthalenylmethanone.
3–Dimethylheptyl–11–hydroxyhexahydrocannabinol.
(9–Hydroxy–6–methyl–3–(5–phenylpentan–2–yl) oxy–5, 6, 6a, 7, 8, 9, 10, 10a–octahydrophenanthridin–1–yl) acetate.
9-(Hydroxymethyl)–6, 6–dimethyl–3–(2–methyloctan–2–yl)–6a, 7, 10, 10a–tetrahydrobenzo[c]chromen–1–ol.
Nabilone.

Any compound structurally derived from 3–(1–naphthoyl)indole or 1H–indol–3–yl–(1–naphthyl)methane by substitution at the nitrogen atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

Any compound structurally derived from 3–(1–naphthoyl)pyrrole by substitution at the nitrogen atom of the pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent.

Any compound structurally derived from 1–(1–naphthylmethyl)indene by substitution at the 3–position of the indene ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.

Any compound structurally derived from 3–phenylacetylindole by substitution at the nitrogen atom of the indole ring with alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent.

Any compound structurally derived from 2–(3–hydroxycyclohexyl)phenol by substitution at the 5–position of the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2–(4–morpholinyl)ethyl, whether or not further substituted in the cyclohexyl ring to any extent.] {re para (c), see fn.115}

2. Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this part of this Schedule.

2A. Any ester or ether of cannabinol or of a cannabinol derivative {110}… [or of a substance for the time being specified in [paragraph 1(ac) or (c)] {120} of this Part of this Schedule].{116}

3. Any salt of a substance for the time being specified in any of paragraph 1 [, 2 or 2A] {111} of this Part of this Schedule.

4. Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.

Part III Class C Drugs.

1. The following substances, namely:

(a) {87}
Alprazolam {33}
Aminorex {91}
Benzphetamine
Bromazepam {34}
7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one {122}
Brotizolam {92}
Buprenorphine {35}
Camezepam {36}
[Cannabis and cannabis resin] moved back to Class B {107}{112}
Cathine {37}
Cathinone {38}
Chlordiazepoxide {39}
Chlorphentermine
Clobazam {40}
Clonazepam {41}
Clorazepic acid {42}
Clotiazepam {43}
Cloxazolam {44}
Delorazepam {45}
Dextropropoxyphene {46}
Diazepam {47}
Diethylpropion {48}
Estazolam {49}
Ethchlorvynol {50}
Ethinamate {51}
Ethyl loflazate {52}

Page 1 | Page 2 | Page 3 | Page 4 | Page 5